Johnpro.com.tw Daily Stats | |
---|---|
Daily Unique Visitors | 43 |
Daily Pageviews | 344 |
Daily Ads Revenue | $0 |
Johnpro.com.tw Monthly Stats | |
---|---|
Monthly Unique Visitors | 1,269 |
Monthly Pageviews | 10,158 |
Monthly Ads Revenue | $10 |
Johnpro.com.tw Yearly Stats | |
---|---|
Yearly Unique Visitors | 15,699 |
Yearly Pageviews | 125,643 |
Yearly Ads Revenue | $126 |
Johnpro.com.tw or simply johnpro receives roughly 344 pageviews (page impressions) daily from it's 43 unique daily visitor. Johnpro was registered and it's hosted on the IP Address Unknown in Unknown, XX. It has an estimated worth of $46 and a global Alexa rank of 3,271,687.
Updated 3 years ago
Domain name | johnpro.com.tw |
Title |
JOHNPRO BIOTECH INC 強普生技 |
Keywords |
Johnpro,癌症治療,抑制癌細胞對於葡萄糖運用,雞尾酒療法,505(b)(2)新藥研發,增敏,抗藥性,季匡華,王愈善,細胞訊息傳遞阻斷劑,藥物奈米化,均質分散技術,微脂體藥物輸送平台,腫瘤細胞能量偵測分析平台,逆轉抗藥性,細胞免疫治療,免疫細胞CAR製造,基因工程全人化抗體製造,靶向治療,標靶治療,白藜蘆醇,薑黃素,化療增敏,標靶藥增敏,癌症新雞尾酒療法,肺癌,腦癌,,,,,,,, |
Description |
強普生技專利癌症增敏劑JP001已獲台灣衛生署核准,進入人體臨床二/三期臨床試驗。JP001為全方位的癌症增敏劑,可以有效延長癌症治療的效果,讓病患有機會可以接受更好的醫療。JP001為本公司獨力研發新複方藥物,依據長期的臨床觀察與經驗推導出特殊之抗癌心法。在實驗室中確認治癌機轉,所開發出以腫瘤微環境及癌症能量代謝為主之系列組合新藥。目前已取得多國專利,並和國際藥廠進行合作技轉。強普生技致力於全方位的癌症治療,期望以全新的治療觀念,帶給癌症病患更好的生活品質。 |
Global Rank | 3,271,687 |
Links in | 0 |
IP Address | Unknown |
Country | XX |
Region | Unknown |
City | Unknown |